| 发明名称 |
14 ALPHA ,17 ALPHA -C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES |
| 摘要 |
The invention describes 14,17-C2-bridged steroids of general formula (I), wherein the various R groups are as defined in the specification, and wherein said steroids are in contrast, with the disclaimed compound, the new compounds are available even after peroral administration with high gestagenic action and are suitable for the production of pharmaceutical agents. |
| 申请公布号 |
WO9620209(A3) |
申请公布日期 |
1996.09.06 |
| 申请号 |
WO1995EP05107 |
申请日期 |
1995.12.23 |
| 申请人 |
SCHERING AKTIENGESELLSCHAFT |
发明人 |
SCHOELLKOPF, KLAUS;HALFBRODT, WOLFGANG;KUHNKE, JOACHIM;SCHWEDE, WOLFGANG;FRITZEMEIER, KARL-HEINRICH;KRATTENMACHER, ROLF;MUHN, HANS-PETER |
| 分类号 |
A61K31/56;A61K31/58;A61P43/00;C07J53/00;C07J71/00 |
主分类号 |
A61K31/56 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
